最新ニュース Vertex (NASDAQ:VERX) 株価情報

VERTEX INC - CLASS A

Vertex

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.

Vertex Inc

Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) has outperformed the market over the past 15 years by 3.06% on an annualized basis producing an average annual return of 14.9%. Currently, Accenture has a market capitalization of $195.28 billion. 
Buying $1000 In ACN: If an investor had bought $1000 of ACN stock 15 years ago, it would be worth $8,006.94 today based on a price of $311.71 for ACN at the time of writing.
<h3>Accenture's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749853812_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In Accenture 15 Years Ago Would Be Worth This Much Today

ORCL&#8217;s early strength confirmed at 10:16 by the TradePulse alert
<figure class="wp-block-image size-large"><img decoding="async" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/13212334/Screenshot-2025-06-13-at-4.55.51%E2%80%AFPM-1006x1024.png" alt="" class="wp-image-14401" /></figure>
Oracle Inc. (ORCL) experienced a Power Inflow today, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.&nbsp;
Today, at 10:16 AM on June 13th, a significant trading signal occurred for Oracle Inc. (ORCL) as it demonstrated a Power Inflow at a price of $206.95. This indicator is crucial for traders who want to know directionally where institutions and so-called "smart money" moves in the market. They see the value of utilizing order flow analytics to guide their trading decisions. The Power Inflow points to a possible uptrend in Oracle's stock, marking a potential entry point for traders looking to capitalize on the expected upward movement. Traders with this signal closely watch for sustained momentum in Oracle's stock price, interpreting this event as a bullish sign.
Signal description
Order flow analytics, aka transaction or market flow analysis, separate and study both the retail and institutional volume rate of orders (flow). It involves analyzing the flow of buy and sell orders, along with size, timing, and other associated characteristics and patterns, to gain insights and make more informed trading decisions. This particular indicator is interpreted as a bullish signal by active traders.&nbsp;
The Power Inflow occurs within the first two hours of the market open and generally signals the trend that helps gauge the stock's overall direction, powered by institutional activity in the stock, for the remainder of the day.&nbsp;
By incorporating order flow analytics into their trading strategies, market participants can better interpret market conditions, identify trading opportunities, and potentially improve their trading performance. But let's not forget that while watching smart money flow can provide valuable insights, it is crucial to incorporate effective risk management strategies to protect capital and mitigate potential losses. Employing a consistent and effective risk management plan helps traders navigate the uncertainties of the market in a more controlled and calculated manner, increasing the likelihood of long-term success
If you want to stay updated on the latest options trades for ORCL, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.&nbsp;
<a href="https://benzinga.com/apis?_gl=1&#x2A;1hlgn5i&#x2A;_ga&#x2A;MTY1NjE2NTYxMi4xNzE0NzQ4MTAy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDc0ODEwMi4xLjEuMTcxNDc0ODQyOC4wLjAuMA..">Market News and Data brought to you by Benzinga APIs</a> and include firms, like <a href="https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025">https://tradepulse.net/?utm_source=Benzinga&amp;utm_medium=Article&amp;utm_campaign=brand_awareness_June2025</a>, which are responsible for parts of the data within this article.
After Market Close UPDATE:
The price at the time of the Power Inflow was $206.95. The returns on the High price ($216.59) and Close price ($215.22) after the Power Inflow are respectively 4.7% and 4%. The result underlines the importance of a trading plan that includes Profit Targets and Stop Losses that reflect your risk appetite.
Past performance is not indicative of future results

Equities

Technicals

Opinion

Signals

ORCL

Oracle Rises 4.7% After Key Trading Signal

CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) has outperformed the market over the past 5 years by 22.82% on an annualized basis producing an average annual return of 36.6%. Currently, CrowdStrike Holdings has a market capitalization of $118.98 billion. 
Buying $100 In CRWD: If an investor had bought $100 of CRWD stock 5 years ago, it would be worth $485.38 today based on a price of $480.00 for CRWD at the time of writing.
<h3>CrowdStrike Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749852913_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CRWD

Here's How Much You Would Have Made Owning CrowdStrike Holdings Stock In The Last 5 Years

General

TIGO

Millicom International Cellular Acquires Telefónica's Telecommunications Operations In Ecuador For $380M

<a href="https://www.whitehouse.gov/presidential-actions/2025/06/regarding-the-proposed-acquisition-of-the-united-states-steel-corporation-by-nippon-steel-corporation/">https://www.whitehouse.gov/presidential-actions/2025/06/regarding-the-proposed-acquisition-of-the-united-states-steel-corporation-by-nippon-steel-corporation/</a>

President Trump On Nippon-U.S. Steel Deal Says Find That Threatened Impairment To National Security Arising As A Result Of The Proposed Transaction Can Be Adequately Mitigated If Some Conditions Are Met; Reserve My Authority To Issue Further Orders With Respect To Purchasers Or U.S. Steel As Shall In My Judgment Be Necessary To Protect National Security

President Trump On Nippon-U.S. Steel Deal Says There Is Credible Evidence That Leads Me To Believe That Purchasers, Through Proposed Transaction, Might Take Action That Threatens To Impair National Security Of The United States

In the current market session, TransMedics Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) share price is at $142.88, after a 0.12% drop. Over the past month, the stock spiked by 17.52%, but over the past year, it actually fell by 0.14%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1749852022_0.png" alt="Past Year Chart" />

<h3>A Look at TransMedics Group P/E Relative to Its Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 51.75 in the Health Care Equipment &amp; Supplies industry, TransMedics Group Inc. has a higher P/E ratio of 100.74. Shareholders might be inclined to think that TransMedics Group Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749852022_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

TMDX

Price Over Earnings Overview: TransMedics Group

Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) has outperformed the market over the past 10 years by 11.22% on an annualized basis producing an average annual return of 22.09%. Currently, Natera has a market capitalization of $22.58 billion. 
Buying $100 In NTRA: If an investor had bought $100 of NTRA stock 10 years ago, it would be worth $735.83 today based on a price of $165.34 for NTRA at the time of writing.
<h3>Natera's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749852014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

NTRA

Here's How Much You Would Have Made Owning Natera Stock In The Last 10 Years

Watts Water Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) has outperformed the market over the past 20 years by 1.79% on an annualized basis producing an average annual return of 10.08%. Currently, Watts Water Technologies has a market capitalization of $7.96 billion. 
Buying $100 In WTS: If an investor had bought $100 of WTS stock 20 years ago, it would be worth $674.12 today based on a price of $238.84 for WTS at the time of writing.
<h3>Watts Water Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749851112_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Watts Water Technologies 20 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-06-13/jpmorgan-readies-6-5-billion-skechers-debt-sale-for-next-week?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-13/jpmorgan-readies-6-5-billion-skechers-debt-sale-for-next-week?embedded-checkout=true</a>

'JPMorgan Readies $6.5 Billion Skechers Debt Sale for Next Week'- Bloomberg

<a href="https://www.reuters.com/business/google-scale-ais-largest-customer-plans-split-after-meta-deal-sources-say-2025-06-13/">https://www.reuters.com/business/google-scale-ais-largest-customer-plans-split-after-meta-deal-sources-say-2025-06-13/</a>

GOOG

GOOGL

'Google, Scale AI's largest customer, plans split after Meta deal, sources say'- Reuters

Trump Media And Technology Registration Statement Has Been Declared Effective By The SEC On June 13, 2025; The Company Has Filed A Corresponding Final Prospectus With The SEC

Management

IOVA

Iovance Biotherapeutics Jean-marc Bellemin To Resign As CFO Effective July 10, 2025

Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has outperformed the market over the past 20 years by 18.75% on an annualized basis producing an average annual return of 27.04%. Currently, Amazon.com has a market capitalization of $2.23 trillion. 
Buying $100 In AMZN: If an investor had bought $100 of AMZN stock 20 years ago, it would be worth $11,885.68 today based on a price of $211.73 for AMZN at the time of writing.
<h3>Amazon.com's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749850229_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

$100 Invested In Amazon.com 20 Years Ago Would Be Worth This Much Today

IMNN

Imunon erminates CFO David Gaiero's Service Agreement; Appoints Kimberly Graper As Interim CFO

KLTO

On June 9, 2025, Klotho Neurosciences Mutually Agreed With Skybell Technologies To Terminate The March 26, 2025 Share Exchange Agreement To Acquire Its SB Security Holdings;  No Liability Incurred From Termination Of Skybell Agreement

CERO

CERo Therapeutics Receives Nasdaq Notice For Bid Price Non-Compliance

ARTL

Artelo Biosciences Regains Nasdaq Minimum Bid Price Compliance

<h3>Gainers</h3>
<ul>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) stock rose 15.2% to $0.71 during Friday's after-market session. The company's market cap stands at $115.5 million. </li>
<li>SS Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSII#NASDAQ">SSII</a>) stock increased by 10.45% to $3.91. The company's market cap stands at $756.9 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares rose 6.93% to $3.7. The company's market cap stands at $69.5 million. </li>
<li>Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) stock moved upwards by 6.62% to $0.77. The company's market cap stands at $59.9 million. </li>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) stock rose 6.35% to $0.34. The company's market cap stands at $14.3 million. </li>
<li>Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares rose 5.93% to $0.19. The company's market cap stands at $24.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock declined by 10.4% to $0.02 during Friday's after-market session. The company's market cap stands at $7.3 million. </li>
<li>Pacific Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) shares fell 9.17% to $1.09. The market value of their outstanding shares is at $327.0 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) shares declined by 8.7% to $0.32. The company's market cap stands at $10.0 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares declined by 8.22% to $0.45. The market value of their outstanding shares is at $2.1 million. </li>
<li>Jupiter Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) stock declined by 7.08% to $1.05. The company's market cap stands at $34.7 million. </li>
<li>Apollomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLM#NASDAQ">APLM</a>) stock fell 7.07% to $6.05. The market value of their outstanding shares is at $6.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

APLM

BMGL

CLDI

ENTO

HCTI

HYPR

IRWD

JUNS

PACB

RLYB

SSII

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Dragonfly Energy Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DFLI#NASDAQ">DFLI</a>) shares increased by 61.6% to $0.49 during Friday's after-market session. The market value of their outstanding shares is at $4.5 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares rose 31.06% to $2.11. The market value of their outstanding shares is at $15.8 million. </li>
<li>Forward Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) shares increased by 9.94% to $22.22. The market value of their outstanding shares is at $676.0 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock increased by 6.18% to $3.09. The market value of their outstanding shares is at $105.4 million. </li>
<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) shares rose 5.91% to $3.4. The market value of their outstanding shares is at $15.7 million. </li>
<li>Volato Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SOAR#AMEX">SOAR</a>) shares increased by 5.45% to $1.74. The company's market cap stands at $3.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Energys Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGS#NASDAQ">ENGS</a>) shares decreased by 15.4% to $2.04 during Friday's after-market session. The market value of their outstanding shares is at $29.0 million. </li>
<li>Robin Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBNE#NASDAQ">RBNE</a>) shares decreased by 8.31% to $12.7. The market value of their outstanding shares is at $30.3 million. </li>
<li>United Maritime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEA#NASDAQ">USEA</a>) stock declined by 7.52% to $1.6. The company's market cap stands at $14.7 million. </li>
<li>Toro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TORO#NASDAQ">TORO</a>) shares fell 6.08% to $2.32. The market value of their outstanding shares is at $44.2 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares fell 5.55% to $1.02. The company's market cap stands at $4.2 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) stock declined by 5.13% to $0.65. The market value of their outstanding shares is at $20.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DFLI

ENGS

FWRD

HYFM

NEOV

RBNE

SGLY

SOAR

TORO

USEA

12 Industrials Stocks Moving In Friday's After-Market Session

Press Releases

Vertex, Inc. to Host 2025 Investor Day

Economics

Vertex Commerce Study: Returnuary's Growing Complexity Forces Retailers to Keep Pace

Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives

Vertex to Announce First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Vertex Announces Strategic Investment in AI Tax Compliance Startup Kintsugi

Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing

Earnings

Vertex Announces First Quarter 2025 Financial Results

Vertex to Present at 20th Annual Needham Technology, Media, & Consumer Conference

Comments

Vertex

ニュース

最新ニュース Vertex (NASDAQ:VERX) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル